Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLeporowski, Axel-
dc.contributor.authorGodman, Brian-
dc.contributor.authorKurdi, Amanj Baker-
dc.contributor.authorMacBride-Stewart, Sean-
dc.contributor.authorRyan, Margaret-
dc.contributor.authorHurding, Simon-
dc.contributor.authorNascimento, Renata Cristina Rezende Macedo do-
dc.contributor.authorBennie, Marion-
dc.contributor.authorMorton, Alec-
dc.identifier.citationLEPOROWSKI, A. et al. Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish National Health System : influence and implications. Expert Review of Pharmacoeconomics & Outcomes Research , v. 16, n. 6, p. 1-19, ago. 2018. Disponível em: <>. Acesso em: 7 mar. 2019.pt_BR
dc.description.abstractBackground: Prescribing of lipid-lowering agents (LLAs) has increased worldwide including in Scotland with increasing prevalence of coronary heart disease, and higher dose statins have been advocated in recent years. There have also been initiatives to encourage prescribing of generic versus patented statins to save costs without compromising care. There is a need to document these initiatives and outcomes to provide future direction. Method: Assessment of utilization (items dispensed) and expenditure of key LLAs (mainly statins) between 2001 and 2015 in Scotland alongside initiatives. Results: Multiple interventions over the years have increased international nonproprietary name prescribing (99% for statins) and preferential prescribing of generic versus patented statins, and reduced inappropriate prescribing of ezetimibe. This resulted in a 50% reduction in expenditure of LLAs between 2001 and 2015 despite a 412% increase in utilization, increased prescribing of higher dose statins (71% in 2015) especially atorvastatin following generic availability, and reduced prescribing of ezetimibe (reduced by 72% between 2010 and 2015). As a result, the quality of prescribing has improved. Conclusion: Generic availability coupled with multiple measures has resulted in appreciable shifts in statin prescribing behavior and reduced ezetimibe prescribing, resulting in improvements in both the quality and efficiency of prescribing.pt_BR
dc.subjectScottish NHSpt_BR
dc.subjectDrug utilizationpt_BR
dc.titleOngoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish National Health System : influence and implications.pt_BR
dc.typeArtigo publicado em periodicopt_BR
Appears in Collections:DEFAR - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
ARTIGO_OngoingActivitesOptimize.pdf1,64 MBAdobe PDFView/Open    Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.